Skip to main content
OpenTrials
Completed

NCT Number: NCT01437917

NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.

The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended. The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

19 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rennes University Hospital

Rennes, Brittany Region, 35033, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy individual,
  • Age between 19-65 years
  • With normal food habits with at least 2 main meals per day
  • Non smoking
  • Having filled the consent form

Exclusion criteria

  • BMI > 25 kg/m2,
  • Diabetes or any illness susceptible to alter
  • Coeliac disease
  • Past history of intestinal diseases.
  • Treatment susceptible of modifying glycemia.
  • Allergy

Treatment and study plan

20% amylose bread

Other

20% amylose bread

10% amylose bread

Dietary Supplement

10% amylose bread

carbohydrates

Dietary Supplement

50g of carbohydrates ingested with 400 ml of water

Primary outcomes

  1. Glycemic index for each bread

    Time frame: 2 hours

    To compare the glycemic index of breads made with different amylose content. (S1 to S6) A total of 6 visits. In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.

Secondary outcomes

  1. AUC for insulinemia for the 2 hours following the ingestion of each bread.

    Time frame: 2 hours

    To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Collaborators

  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Registry information

Acronym: NOMAC

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Sep 21, 2011
Registry last updated
May 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.